JP2009502921A5 - - Google Patents

Download PDF

Info

Publication number
JP2009502921A5
JP2009502921A5 JP2008523972A JP2008523972A JP2009502921A5 JP 2009502921 A5 JP2009502921 A5 JP 2009502921A5 JP 2008523972 A JP2008523972 A JP 2008523972A JP 2008523972 A JP2008523972 A JP 2008523972A JP 2009502921 A5 JP2009502921 A5 JP 2009502921A5
Authority
JP
Japan
Prior art keywords
compound
independently
composition
cancer
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008523972A
Other languages
English (en)
Japanese (ja)
Other versions
JP5255438B2 (ja
JP2009502921A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/028149 external-priority patent/WO2007015923A2/en
Publication of JP2009502921A publication Critical patent/JP2009502921A/ja
Publication of JP2009502921A5 publication Critical patent/JP2009502921A5/ja
Application granted granted Critical
Publication of JP5255438B2 publication Critical patent/JP5255438B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008523972A 2005-07-26 2006-07-21 プロテインキナーゼ阻害薬として有用なベンズイミダゾール Expired - Fee Related JP5255438B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70239905P 2005-07-26 2005-07-26
US60/702,399 2005-07-26
PCT/US2006/028149 WO2007015923A2 (en) 2005-07-26 2006-07-21 Benzimidazoles useful as inhibitors of protein kinases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013025417A Division JP2013082757A (ja) 2005-07-26 2013-02-13 プロテインキナーゼ阻害薬として有用なベンズイミダゾール

Publications (3)

Publication Number Publication Date
JP2009502921A JP2009502921A (ja) 2009-01-29
JP2009502921A5 true JP2009502921A5 (cg-RX-API-DMAC7.html) 2009-09-03
JP5255438B2 JP5255438B2 (ja) 2013-08-07

Family

ID=37680602

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008523972A Expired - Fee Related JP5255438B2 (ja) 2005-07-26 2006-07-21 プロテインキナーゼ阻害薬として有用なベンズイミダゾール
JP2013025417A Withdrawn JP2013082757A (ja) 2005-07-26 2013-02-13 プロテインキナーゼ阻害薬として有用なベンズイミダゾール

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013025417A Withdrawn JP2013082757A (ja) 2005-07-26 2013-02-13 プロテインキナーゼ阻害薬として有用なベンズイミダゾール

Country Status (17)

Country Link
US (1) US8076343B2 (cg-RX-API-DMAC7.html)
EP (2) EP1937667B1 (cg-RX-API-DMAC7.html)
JP (2) JP5255438B2 (cg-RX-API-DMAC7.html)
KR (1) KR20080034483A (cg-RX-API-DMAC7.html)
CN (1) CN101291927A (cg-RX-API-DMAC7.html)
AT (1) ATE484501T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006276088A1 (cg-RX-API-DMAC7.html)
CA (1) CA2616159A1 (cg-RX-API-DMAC7.html)
DE (1) DE602006017574D1 (cg-RX-API-DMAC7.html)
ES (1) ES2351357T3 (cg-RX-API-DMAC7.html)
IL (1) IL188942A0 (cg-RX-API-DMAC7.html)
NO (1) NO20080967L (cg-RX-API-DMAC7.html)
NZ (1) NZ566021A (cg-RX-API-DMAC7.html)
RU (1) RU2415853C2 (cg-RX-API-DMAC7.html)
TW (1) TW200745088A (cg-RX-API-DMAC7.html)
WO (1) WO2007015923A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200800992B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7989465B2 (en) 2007-10-19 2011-08-02 Avila Therapeutics, Inc. 4,6-disubstituted pyrimidines useful as kinase inhibitors
JP5600063B2 (ja) 2007-10-19 2014-10-01 セルジーン アビロミクス リサーチ, インコーポレイテッド ヘテロアリール化合物およびその使用
US9273077B2 (en) 2008-05-21 2016-03-01 Ariad Pharmaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
JP2011523646A (ja) 2008-05-21 2011-08-18 アリアド・ファーマシューティカルズ・インコーポレイテッド キナーゼ阻害剤としてのリン誘導体
AU2012250517B2 (en) 2011-05-04 2016-05-19 Takeda Pharmaceutical Company Limited Compounds for inhibiting cell proliferation in EGFR-driven cancers
JP6469567B2 (ja) 2012-05-05 2019-02-13 アリアド・ファーマシューティカルズ・インコーポレイテッド Egfr発動性がんの細胞増殖阻害用化合物
US9336046B2 (en) 2012-06-15 2016-05-10 International Business Machines Corporation Transaction abort processing
US9512136B2 (en) * 2012-11-26 2016-12-06 Universal Display Corporation Organic electroluminescent materials and devices
EP2976336A1 (en) * 2013-03-21 2016-01-27 Bayer Pharma Aktiengesellschaft 3-heteroaryl substituted indazoles
US9611283B1 (en) 2013-04-10 2017-04-04 Ariad Pharmaceuticals, Inc. Methods for inhibiting cell proliferation in ALK-driven cancers
WO2014170421A1 (en) * 2013-04-19 2014-10-23 F. Hoffmann-La Roche Ag Serine/threonine kinase inhibitors
ITUA20164278A1 (it) * 2016-06-10 2017-12-10 International Soc For Drug Development S R L COMPOSTI 2-OXO-1,2-DIIDROPIRIDIN-3-CARBOSSAMMIDE E LORO USO COME INIBITORI DUALI DI PDK1/AurA
AU2018352695A1 (en) 2017-10-19 2020-05-28 Effector Therapeutics, Inc. Benzimidazole-indole inhibitors of Mnk1 and Mnk2
CN112552287B (zh) * 2020-12-16 2021-11-30 北京华氏精恒医药科技有限公司 一种吲哚类衍生物药物制剂及其制备方法
CN118055931A (zh) * 2021-12-23 2024-05-17 杭州多域生物技术有限公司 一种五元并六元化合物、制备方法、药物组合物和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE305465T1 (de) 1998-11-17 2005-10-15 Kumiai Chemical Industry Co Pyrimidinylbenzimidazol- und triazinylbenzimidazol-derivate und agrikulte/hortikulte fungizide
JP4535350B2 (ja) * 1998-11-17 2010-09-01 クミアイ化学工業株式会社 ピリミジニルベンズイミダゾール誘導体及び農園芸用殺菌剤
MXPA02003436A (es) * 1999-10-07 2002-08-20 Amgen Inc Inhibidores de triazina cinasa.
KR20030024659A (ko) 2000-02-17 2003-03-26 암겐 인코포레이티드 키나제 억제제
KR100833371B1 (ko) * 2001-04-27 2008-05-28 젠야쿠코교가부시키가이샤 헤테로시클릭 화합물 및 이를 유효 성분으로 하는 항종양제
FR2833948B1 (fr) * 2001-12-21 2004-02-06 Sod Conseils Rech Applic Nouveaux derives de benzimidazole et leur utilisation en tant que medicament
ATE457025T1 (de) * 2002-05-23 2010-02-15 Cytopia Res Pty Ltd Kinaseinhibitoren
AR042052A1 (es) * 2002-11-15 2005-06-08 Vertex Pharma Diaminotriazoles utiles como inhibidores de proteinquinasas
UA80767C2 (en) * 2002-12-20 2007-10-25 Pfizer Prod Inc Pyrimidine derivatives for the treatment of abnormal cell growth
ES2389203T3 (es) * 2004-01-12 2012-10-24 Ym Biosciences Australia Pty Ltd Inhibidores de quinasa selectivos

Similar Documents

Publication Publication Date Title
JP7861083B2 (ja) Fak阻害剤およびその併用薬物
KR20170082637A (ko) 단백질 키나아제 억제제로서의 6-아미노-7-바이사이클로-7-데아자-퓨린 유도체
JP2011511095A5 (cg-RX-API-DMAC7.html)
JP2014503567A5 (cg-RX-API-DMAC7.html)
JP2004529161A5 (cg-RX-API-DMAC7.html)
JP2012505235A5 (cg-RX-API-DMAC7.html)
JP2016525076A5 (cg-RX-API-DMAC7.html)
JP2013529196A5 (cg-RX-API-DMAC7.html)
TWI534149B (zh) Using imidazo and Anti-tumor effect enhancer for compounds
KR20140117439A (ko) 피리돈 유도체들
JP2010540509A5 (cg-RX-API-DMAC7.html)
JP2016525075A5 (cg-RX-API-DMAC7.html)
JP2018532737A5 (cg-RX-API-DMAC7.html)
EA028319B1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
JP2011509949A5 (cg-RX-API-DMAC7.html)
CN107074807A (zh) 用于抑制组蛋白脱甲基酶的组合物和方法
CN107567445B (zh) 可用作哺乳动物酪氨酸激酶ror1活性抑制剂的2-苯基-3h-咪唑并[4,5-b]吡啶衍生物
JP2017504576A5 (cg-RX-API-DMAC7.html)
JP2015509098A5 (cg-RX-API-DMAC7.html)
RU2020102453A (ru) Фармацевтические композиции
WO2021022076A1 (en) Molecules and methods related to treatment of uncontrolled cellular proliferation
RU2008106949A (ru) Бензимидазолы применимые в качестве ингибиторов протеинкиназ
JP2020527173A5 (cg-RX-API-DMAC7.html)
TW202003507A (zh) 具有四氫吡喃基甲基之吡啶酮衍生物及其用途
EA026729B1 (ru) Замещенные тетрагидрокарбазольные и карбазолкарбоксамидные соединения